Filing Details
- Accession Number:
- 0001225208-22-012777
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-14 16:37:19
- Reporting Period:
- 2022-12-13
- Accepted Time:
- 2022-12-14 16:37:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 885725 | Boston Scientific Corp | BSX | Surgical & Medical Instruments & Apparatus (3841) | 042695240 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1484186 | Michael Joseph Fitzgerald | 300 Boston Scientific Way Marlborough MA 01752-1234 | Evp & Group Pres, Cardiology | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-07-29 | 1,000 | $0.00 | 216,871 | No | 5 | G | Direct | |
| Common Stock | Acquisiton | 2022-12-13 | 79,264 | $7.39 | 296,135 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-12-13 | 79,264 | $47.78 | 216,871 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | G | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-12-13 | 79,264 | $0.00 | 79,264 | $7.39 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-02-28 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 68,082 | Indirect | By 401(k) |
| Common Stock | 7,428 | Indirect | By Children |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
- Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
- The reporting person disclaims beneficial ownership of the shares held by his children, and this report should not be deemed an admission that the reporting person is the beneficial owner of his children's shares for purposes of Section 16 or for any other purpose.
- Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.
Billionaire Hedge Funds
